IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$1.31 USD
+0.04 (3.15%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.31 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
IGM Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IGMS 1.31 +0.04(3.15%)
Will IGMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IGMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IGMS
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
IGMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Other News for IGMS
IGM Biosciences (IGMS) Shares Surge After Acquisition Announcement
IGM Biosciences climbs on merger deal with Concentra
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1. ...
IGM Biosciences be acquired by Concentra for $1.247 in cash per share
IGM Biosciences moved to No Rating at BofA